Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03056859 · ClinicalTrials.gov registry record
Compass Device CVC Trial
A clinical trial, sponsored by University of New Mexico.
- Completed
- Registry status
- 20
- Enrollment target
NCT03056859: Completed study, sponsored by University of New Mexico.
NCT03056859 is a clinical trial that has completed, run by University of New Mexico. The registered enrollment target is 20 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03056859 has completed, sponsored by University of New Mexico.
- COMPLETED
- Registry status
- 20 participants
- Enrollment target
Study Summary
This is a single-arm observational trial of a device (Compass Vascular Access, Centurion Medical Products, Williamston MI). The device is a compact, sterile, single-use extravascular blood pressure transducer. This pressure measurement aids in confirmation of appropriate venous access. The investigators plan to enroll 40 consenting patients with BMI ≥35 who require central venous catheterization for clinical reasons independent of the existence of this study. The primary outcome is operator satisfaction.
Primary Outcome
Operator satisfaction (0-10 scale; 0=totally dissatisfied, 10=totally satisfied)
Interventions
- DEVICE Extravascular blood pressure transducer
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 20 participants |
| Start Date | 2017-02-17 |
| Est. Completion | 2020-02-10 |
What the finished NCT03056859 record still lists
NCT03056859 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 20 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Extravascular blood pressure transducer is the first listed.
NCT03056859 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03056859 about?
NCT03056859 is a clinical study titled "Compass Device CVC Trial". This is a single-arm observational trial of a device (Compass Vascular Access, Centurion Medical Products, Williamston MI). The device is a compact, sterile, single-use extravascular blood pressure transducer. This pressure measurement aids in confirmation of appropriate venous access. The investiga...
What is the current status of trial NCT03056859?
This trial is currently completed. The enrollment target is 20 participants. The study started on 2017-02-17. Estimated completion is 2020-02-10.
What interventions are being tested in trial NCT03056859?
The interventions under investigation include: Extravascular blood pressure transducer (DEVICE).
Who is sponsoring clinical trial NCT03056859?
This trial is sponsored by University of New Mexico, which has 168 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00573339 · 20 participants
Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing
- NCT00692939 · 20 participants · Phase 1
Autologous Stem Cell Transplantation for Crohn's Disease
- NCT00967785 · 20 participants · Phase 1
A Phase I Study of Mozobil in the Treatment of Patients With WHIMS
- NCT01406691 · 20 participants · Phase 4
Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI